On April 2, 2019, the Food and Drug Administration issued a statement by Commissioner Scott Gottlieb on steps toward a new review framework specifically tailored to promote the development of medical ...

Depression is a chronic and progressive condition that, when not treated adequately, can lead to severe morbidity and mortality in patients and increased costs for health plans. Despite the ...